Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Cheryl Olson"'
Publikováno v:
Rare Tumors, Vol 13 (2021)
A case of pheochromocytoma producing vasoactive intestinal peptide (VIP) and left ventricular thrombus in the absence of cardiomyopathy or wall motion abnormalities on echocardiogram is presented along with a review of the relevant literature. A 30-y
Externí odkaz:
https://doaj.org/article/95ba33055a0346aab1dc19aff78deb00
Autor:
Jiabo Li, Xuya Wang, Steven Markwell, Tatiana Carneiro-Lobo, Cheryl Olson, Ling-Kai Shih, Luqing Tong, Xuejun Yang, Daniel Brat
Publikováno v:
Neuro-Oncology. 24:vii275-vii276
Glioblastoma, IDH-wildtype (GBM, WHO grade 4) is the most common primary intracranial malignant tumor of adults and is characterized by an immunosuppressive tumor micro-environment (TME) and poor clinical outcomes. CLEC5A is a protein-coding gene inv
Autor:
Tatiana Carneiro-Lobo, Cheryl Olson, Steven Markwell, Pinar Mesci, Alysson Muotri, Daniel Brat
Publikováno v:
Neuro-Oncology. 24:vii279-vii279
Patients with glioblastoma (GBM) have an overall survival of 15 months. These catastrophic survival rates are correlated with systematic relapses that might arise from remaining glioblastoma stem cells (GSCs) left behind after treatments. Our goal wa
Publikováno v:
Neuro-Oncology. 24:vii282-vii282
Glioblastoma (GBM) is the most common and malignant primary brain tumor with pre-necrotic and post-necrotic growth phases. The development of necrosis is associated with extensive tumor micro-environmental (TME) rearrangement and rapid biologic advan
Autor:
Subhas Mukherjee, Gary Schiltz, Matt Clutter, Rama Mishra, Cheryl Olson, Bilge Dunder, Nitya Sharma, Steven Markwell, Daniel Brat
Publikováno v:
Neuro Oncol
The survival advantage of glioma stem cells (GSCs) represents a critical mechanism for growth, therapy resistance and recurrence in glioblastoma. So far, targeting GSCs has not been highly specific, since these cells co-opt the normal developmental s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2fca9f6dc1531227df41c5d346818ba
https://europepmc.org/articles/PMC6846902/
https://europepmc.org/articles/PMC6846902/
Publikováno v:
Neuro Oncol
Glioblastoma is a WHO Grade IV malignant brain tumor with a 95% mortality rate within 2–5 years of diagnosis. This prognosis has not improved in the last 30 years, and with standardized radiation therapy, the cancer always recurs. It is not yet cle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::277e17f33bbed5be1952491b37a352ac
https://europepmc.org/articles/PMC6847569/
https://europepmc.org/articles/PMC6847569/
Publikováno v:
Rare Tumors, Vol 13 (2021)
Rare Tumors
Rare Tumors
A case of pheochromocytoma producing vasoactive intestinal peptide (VIP) and left ventricular thrombus in the absence of cardiomyopathy or wall motion abnormalities on echocardiogram is presented along with a review of the relevant literature. A 30-y
Uncontrolled hemorrhage is the major cause of death among warfighters. Hemostatic dressing products have been introduced to treat combat casualties in the field. The objectives of the present report are to provide an assessment of current and develop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::594e12b0fbe86045bb0f49824f68b236
https://doi.org/10.21236/ada477227
https://doi.org/10.21236/ada477227